Steep Hill Study Provides Evidence of Substantial Pesticide Contamination in California Cannabis Clones
Pesticide use during clone production remains present through the growth cycle of the plant
BERKELEY, Calif. - September 25, 2017 (Investorideas.com Newswire) Steep Hill Labs, Inc., the global industry leader in cannabis testing and analytics, today released a study, entitled "Study of Pesticides in Cannabis Plant Clones" (see http://landing.steephill.com/cleanclones for the full white paper) which shows that – whether through direct use or via cross-contamination – the presence of pesticides in the California cannabis supply is endemic and can be sourced to the persistent presence of pesticides in clones.
In making the announcement, CEO Jmichaele Keller said, "When we released the first study on pesticides in October of 2016, many growers approached Steep Hill saying that they did not use pesticides, they were organic, they were trying to do the right thing for their patients and consumers. After hearing this over and over again, we knew there was something wrong in the supply chain. It dawned on me, IT'S IN THE CLONES. We started formulating a plan to discover the root of the problem, because our mission is to make sure that growers have all of the tools and expertise needed to succesfully pass new California regulations. We undertook this study to understand the concern of our clients who were also perplexed by the pesticide reports we were issuing. The conclusions in the attached study indicate a significant number of failures at the clone stage. We realized that serious problems in the California cannabis supply chain could result in 2018 if the very source material from which the cannabis was being grown for large scale production was already contaminated with pesticides failing current regulations. We at Steep Hill want to work together with California regulators, growers, product manufacturers and the medical community to solve this problem for the safety and success of the California cannabis supply."
"The report documents clone sources and locations, descriptions of how samples were prepared and analyzed, and the comprehensive findings," Reggie Gaudino, Ph.D and author of the study remarked. "A crucial issue in the industry is that very few growers are breeding to deliver genetic stability, unlike other crops which have been stabilized over decades utilizing sophisticated agricultural processes. Stable genetic lines provide the ability to grow from seed and thus produce hardy, reproducible product. We need to work together to insure that traditional practices in the industry are re-examined and changed in light of this data."
Donald Land, Ph.D, and a co-author of the report remarked, "When the 'mothers' of clones are contaminated with pesticides, particularly those that are systemic, so too are the clone offspring. We look forward to working with the California cannabis industry to establish best practices to substantially reduce the need for the use of pesticides as a whole, and to help set the standard for clean clone production in the future."
Authors of this study include: Anthony Torres, Wilson Linker, Donald Land Ph.D, Reggie Gaudino, Ph.D.
For more information about cannabis testing, please visit the Steep Hill website: http://steephill.com
ABOUT STEEP HILL
Steep Hill Labs, Inc. is the world's leading cannabis science and technology company with extensive expertise in lab testing, remote testing, genetics, R&D, and the licensing of our intellectual property to strategic partners across the globe. No other cannabis company brings each of these areas of expertise into one highly synergistic whole. Steep Hill's foundation was built on testing and analyzing medical and recreational marijuana to ensure compliance with public safety standards. In 2008, Steep Hill opened the first commercial cannabis lab in the United States and the company has been on the cutting edge since its inception. Steep Hill is expanding throughout the United States, and globally. With the goal of helping the rest of the world adopt "best practices" in cannabis testing, the company also provides expert consulting services to legislators and regulators in many countries, states, and municipalities around the world.
Cathie Bennett Warner
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Watch the 420 Cannabis Investor video
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.